Summary

The Measles Vaccine market will reach xxx Million USD in 2019 with CAGR xx% 2019-2025. The main contents of the report including:

market size and forecast

Regional market size, production data and export & import

Key manufacturers profile, products & services, sales data of business

market size by Major Application

market size by Major Type

Key manufacturers are included based on company profile, sales data and product specifications etc.:

GSK

Sanofi-Pasteur

Merck

Novartis

Pfizer

Serum Institute of India

China National Biotech Group

Bavarian Nordic

Emergent Biosolutions

Medimmune

Johnson & Johnson

CSL Limited

Major applications as follows:

Children

Adults

Major Type as follows:

Mumps Measles Rubella Vaccine, Live (MMR-II)

Mumps Measles Rubella and Varicella Virus Vaccine (Proquad)

Regional market size, production data and export & import:

Asia-Pacific

North America

Europe

South America

Middle East & Africa

Table of Contents
1 Market Overview
1.1 Scope of Statistics
1.1.1 Scope of Products
1.1.2 Scope of Manufacturers
1.1.3 Scope of Application
1.1.4 Scope of Type
1.1.5 Scope of Regions/Countries
1.2 Market Size
2 Regional Market
2.1 Regional Production
2.2 Regional Demand
2.3 Regional Trade
3 Key Manufacturers
3.1 GSK
3.1.1 Company Information
3.1.2 Product & Services
3.1.3 Business Data (Capacity, Sales Revenue, Volume, Price, Cost and Margin)
3.1.4 Recent Development
3.2 Sanofi-Pasteur
3.2.1 Company Information
3.2.2 Product & Services
3.2.3 Business Data (Capacity, Sales Revenue, Volume, Price, Cost and Margin)
3.2.4 Recent Development
3.3 Merck
3.3.1 Company Information
3.3.2 Product & Services
3.3.3 Business Data (Capacity, Sales Revenue, Volume, Price, Cost and Margin)
3.3.4 Recent Development
3.4 Novartis
3.4.1 Company Information
3.4.2 Product & Services
3.4.3 Business Data (Capacity, Sales Revenue, Volume, Price, Cost and Margin)
3.4.4 Recent Development
3.5 Pfizer
3.5.1 Company Information
3.5.2 Product & Services
3.5.3 Business Data (Capacity, Sales Revenue, Volume, Price, Cost and Margin)
3.5.4 Recent Development
3.6 Serum Institute of India
3.6.1 Company Information
3.6.2 Product & Services
3.6.3 Business Data (Capacity, Sales Revenue, Volume, Price, Cost and Margin)
3.6.4 Recent Development
3.7 China National Biotech Group
3.7.1 Company Information
3.7.2 Product & Services
3.7.3 Business Data (Capacity, Sales Revenue, Volume, Price, Cost and Margin)
3.7.4 Recent Development
3.8 Bavarian Nordic
3.8.1 Company Information
3.8.2 Product & Services
3.8.3 Business Data (Capacity, Sales Revenue, Volume, Price, Cost and Margin)
3.8.4 Recent Development
3.9 Emergent Biosolutions
3.9.1 Company Information
3.9.2 Product & Services
3.9.3 Business Data (Capacity, Sales Revenue, Volume, Price, Cost and Margin)
3.9.4 Recent Development
3.10 Medimmune
3.10.1 Company Information
3.10.2 Product & Services
3.10.3 Business Data (Capacity, Sales Revenue, Volume, Price, Cost and Margin)
3.10.4 Recent Development
3.11 Johnson & Johnson
3.11.1 Company Information
3.11.2 Product & Services
3.11.3 Business Data (Capacity, Sales Revenue, Volume, Price, Cost and Margin)
3.12 CSL Limited
3.12.1 Company Information
3.12.2 Product & Services
3.12.3 Business Data (Capacity, Sales Revenue, Volume, Price, Cost and Margin)
4 Major Application
4.1 Children
4.1.1 Overview
4.1.2 Children Market Size and Forecast
4.2 Adults
4.2.1 Overview
4.2.2 Adults Market Size and Forecast
5 Market by Type
5.By Mumps Measles Rubella Vaccine, Live (MMR-II)
5.1 Mumps Measles Rubella Vaccine, Live (MMR-II)
5.1.1 Overview
5.1.2 Mumps Measles Rubella Vaccine, Live (MMR-II) Market Size and Forecast
5.2 Mumps Measles Rubella and Varicella Virus Vaccine (Proquad)
5.2.1 Overview
5.2.2 Mumps Measles Rubella and Varicella Virus Vaccine (Proquad) Market Size and Forecast
6 Price Overview
6.1 Price by Manufacturers
6.2 Price by Application
6.3 Price by Type
7 Conclusion